Familial insulin-resistant diabetes secondary to an affinity defect of the insulin receptor
✍ Scribed by H. W. Rüdiger; M. Dreyer; J. Kühnau; H. Bartelheimer
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 434 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
✦ Synopsis
We describe three siblings with a mild diabetes mellitus in combination with acanthosis nigricans and multiple minor physical abnormalities. Fasting plasma insulin was elevated up to 100-fold as compared with normal values, and the diabetes was classified as insulin resistant. Insulin-binding studies on erythrocytes, monocytes, and cultured fibroblasts disclosed an abnormally reduced binding capacity, as compared with that of healthy controls, which was most prominent at low concentrations of insulin. Scatchard analysis on erythrocytes of the three patients revealed a normal number of total insulin-binding sites per cell, but a complete lack of insulin binding to the high-affinity receptor component. The findings are consistent with the assumption of two genetically distinct types of insulin receptors.
📜 SIMILAR VOLUMES
## Non-insulin-dependent diabetes mellitus As both insulin secretion and insulin action (NIDDM) is, according to the World Health are controlled genetically, mutations in genes Organization (WHO) definition, diagnosed on encoding for either hormone secretion, or its the basis of raised plasma gluc
The possibility of linkage between the human insulin receptor gene locus and diabetes was examined in three Type 2 (non-insulin-dependent) diabetic families and one family with maturity onset diabetes of the young. Insulin receptor gene haplotypes were established using BglII, Rsal and Sstl restrict
Insulin resistance of skeletal muscle, liver and fat combined with an abnormality of insulin secretion characterizes Type 2 (non-insulin-dependent) diabetes mellitus. There is increasing evidence that the insulin resistance of the skeletal muscle plays a key role early in the development of Type 2 d